WC
BTAL icon

Waterloo Capital’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Waterloo Capital’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,300
Closed -$477K – 362
2024
Q2 		$477K Buy
+24,300
New +$461K 0.06% 227
2023
Q3 		– Sell
-60,053
Closed -$1.13M – 192
2023
Q2 		$1.13M Sell
60,053
-25,012
-29% -$504K 0.33% 55
2023
Q1 		$1.74M Buy
+85,065
New +$1.71M 0.54% 39
2020
Q1 		$315K Buy
+12,280
New +$292K 0.22% 101

Other funds holding BTAL

TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.56B AUM 22.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return

Waterloo Capital's BTAL Position: Q3 2024 in Review

Waterloo Capital sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2024, closing a stake of 24,300 shares — an estimated $477K sold.

Waterloo Capital first reported a position in BTAL in Q1 2020 and held it in 4 quarters. The position peaked at $1.74M in Q1 2023. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2024.

  • Waterloo Capital reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2024 after selling out during the quarter.
  • Waterloo Capital sold 24,300 AGF US Market Neutral Anti-Beta Fund shares in Q3 2024, an estimated $477K.
  • Waterloo Capital first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2020 and held it in 4 quarters.
  • Waterloo Capital's AGF US Market Neutral Anti-Beta Fund position peaked at $1.74M in Q1 2023.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2024.

Based on Waterloo Capital's 13F filing for Q3 2024, filed 14 Nov 2024.